Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Operating Expenses | 3,096 | 7,500 | 4,339 | 3,045 | 1,572 |
| Operating Income | -3,096 | -7,500 | -4,339 | -3,045 | -1,572 |
| Interest Expense | 632 | 1,750 | 173 | 704 | 96 |
| Other Income | -2,239 | -2,570 | -2,663 | 171 | -242 |
| Pre-tax Income | -5,967 | -11,820 | -7,175 | -3,578 | -1,910 |
| Income Tax | 7 | -1 | -38 | 6 | 5 |
| Net Income Continuous | -5,974 | -11,841 | -7,137 | -3,584 | -1,915 |
| Net Income | $-5,974 | $-11,841 | $-7,137 | $-3,572 | $-1,905 |
| EPS Basic Total Ops | -40.00 | -79.52 | -48.00 | -24.00 | -12.80 |
| EPS Basic Continuous Ops | -40.04 | -79.58 | -47.96 | -24.08 | -12.87 |
| EPS Diluted Total Ops | -40.00 | -79.52 | -48.00 | -24.00 | -12.80 |
| EPS Diluted Continuous Ops | -40.04 | -79.58 | -47.96 | -24.08 | -12.87 |
| EBITDA(a) | $-2,599 | $-7,012 | $-3,844 | $-2,867 | $-1,553 |